The United States Proton Therapy market had reached US$1.04 billion in 2024 and is estimated to reach US$2.67 billion during the forecast period from 2025 to 2033 at a compound annual growth rate of 10.97%. Increasing incidence of cancer, technology advancement in proton therapy, and need for non-invasive precise treatments in patients suffering from cancer stimulate growth in the proton therapy market. With growing awareness of the benefits in the United States, the market is assumed to expand greatly as it will establish it a global leader in advanced care for cancer.
Proton Therapy Market Outlooks
Proton therapy is a highly advanced form of radiation that utilizes protons instead of X-rays for cancer treatment. Narrower radiation margins because of precise treatment which will harm cancer cells less than other tissues surrounding will make it especially suitable for use near vital organs such as the brain, spine, or heart. Among the advantages of proton therapy: Reduction of side effects and high outcome percents have helped many to take advantage of it in a bid to treat various forms of cancers like pediatric cancers, prostate cancer, and head and neck cancers.
Proton therapy is fast being adopted in the United States, where its efficiency and growing awareness among patients and healthcare providers are contributing factors. Proton therapy consumes the greatest number of therapies in the United States, which boasts of a highly developed health care infrastructure and several proton therapy centers. With cancer incidence projected to rise worldwide, growing technological advancements in proton therapy spur demand in the treatment. Proton therapy insurance is also becoming more accessible, thereby opening more access to more patients in the country.
Growth Driver in the United States Proton Therapy Industry
Increasing Cancer Incidence in USA
The increasing incidence of cancer is the most significant growth driver for the proton therapy market. Every year, millions of new cancer cases are diagnosed in the United States, and most of them require advanced treatment. Proton therapy is much more precise radiation treatment without the destruction of surrounding healthy tissues. It would be very ideal for children and cancers located at close proximity to critical organs. With the continued increase in cancer incidence, an increasing need for effective and less-invasive treatments like proton therapy stimulates the development of proton therapy centers around the country. According to Pubmed, new cases of cancer that are bound to be registered in the United States amount to 2,001,140 and 611,720 cancer deaths in 2024.
Technological Advancements in Proton Therapy
New technology advancements have witnessed a great share in the growth of the proton therapy market in the United States. Most of its recent developments including pencil beam scanning and image-guided proton therapy have improved the precision and velocity of treatments. This is, therefore, making proton therapy much more appealing. Other benefits are smaller size designs for proton therapy systems that decrease both the cost and space requirements, thus making it possible for more treatment facilities to offer this type of treatment. Advances enhance patient outcome with a lower total cost of care. In addition, as newer technology becomes available, access to proton therapy, as well as its effectiveness when applied to cancer treatment, increases. January 2024, The National Association for Proton Therapy (NAPT) released a new study in the International Journal of Radiation Oncology-Biology-Physics, which summarizes the application of proton therapy in treating various diseases and tumor locations.
Expanding Insurance Coverage
Another reason why the proton therapy industry is doing so well is due to the expansion of insurance coverage in the United States. Generally, one of the significant contributory factors to the generally restricted access to the therapy has been its expensive treatment costs. However, increasing knowledge of its benefits, increasingly more insurance is underwriting it for various kinds of cancers, especially when other traditional forms of radiation therapy risk causing more side effects. Such broad coverage makes the therapy available to an all-inclusive range of patients, thus the demand increases. Improvement of reimbursement policies will encourage the proton therapy market in the coming future. The UC Board of Regents has also cleared for construction a next-generation UCSF cancer treatment center, UCSF research space, a life sciences incubator, and primary and specialty care clinics as part of the redevelopment of the Dogpatch Power Station in southeast San Francisco.
California Proton Therapy Industry
The proton therapy industry in California is booming due to its well-developed healthcare infrastructure and growing numbers of cancer patients in the state. It's on the front edge of innovation in cancer treatment and contains some of the world's most impressive proton therapy centers, including Los Angeles and San Diego, California. The focus of the state on personalized medicine and its non-invasive approach drives high demand for proton therapy. Growing public awareness of the advantages of proton therapy and support at the state level for advanced medical technology are further advancing the industry. California is likely to be the leader in the global market of proton therapy for a long time.
United States Proton Therapy Company Analysis
Some major companies in the United States proton therapy industry are IBA, Varian Medical System, Hitachi Ltd, Mevion Medical Systems, and Mitsubishi Electric Corporation.
United States Proton Therapy Company News
- June 2024 - Atlantic Health System plans to acquire and install a MEVION Proton Therapy System™ at the Carol G. Simon Cancer Center in New Jersey, scheduled for installation in 2025.
- March 2023, The first participant in a clinical trial of FLASH proton therapy for chest bone cancers has completed treatment at the Cincinnati Children's/University of Cincinnati Medical Center Proton Therapy Center.
- In March 2022, Tractebel and IBA signed a partnership agreement to strengthen their cooperation in proton therapy. IBA will promote Tractebel’s engineering services to prospective customers for designing and building proton therapy facilities.
Indication- Industry is divided into 6 viewpoints:
- Head & Neck Cancer
- Sarcoma
- Pediatric Cancer
- Gastro-intestinal Cancer
- Prostate Cancer
- Lung Cancer
Set-up Type- Industry is divided into 2 viewpoints
- Single Room
- Multi - Room
United States- Industry is divided into 24 States
- California (CA)
- Massachusetts (MA)
- Texas (TX)
- Florida (FL)
- Oklahoma (OK)
- Pennsylvania (PA)
- Illinois (IL)
- Virginia (VA)
- New Jersey (NJ)
- Washington (WA)
- Missouri (MO)
- Tennessee (TN)
- Louisiana (LA)
- Minnesota (MN)
- Arizona (AZ)
- Maryland (MD)
- Ohio (OH)
- Michigan (MI)
- District of Columbia (DC)
- Georgia (GA)
- New York (NY)
- Alabama (AL)
- Utah (UT)
- Arkansas (AR)
Reimbursement Policy
- Reimbursement Policies for Patients
- Reimbursement for Institutions, Stakeholders and Manufacturers
Components of a Standard Proton Therapy Center
Proton Accelerator
- Synchrotrons (example: LLUMC at Loma Linda)
- Cyclotrons (example: MGH Boston)
- Synchrocyclotrons (examples: Orsay, Uppsala)
- Linacs (Rome)
- H-minus Synchrotrons
- Separated Sector Cyclotrons
- Super-conducting Cyclotrons
- Fast Cycling Synchrotron
Beam Transport System
- Beam Delivery System
- The Passive Scattering Technique
- Beam Scanning
Nozzle
- Single Scattering
- Double Scattering
- Uniform Scanning Nozzle
- Pencil Scanning Nozzle
Treatment Planning System
- Image Viewers
- Patient Positioning System (PPS)
- Human Resource
All companies have been covered from 4 viewpoints
- Business overview
- Key Persons
- Recent Development & Strategies
- Sales Analysis
Key Players Analysis
- IBA
- Varian Medical System
- Hitachi Ltd.
- Mevion Medical Systems
- Mitsubishi Electric Corporation
Table of Contents
Companies Mentioned
- IBA
- Varian Medical System
- Hitachi Ltd.
- Mevion Medical Systems
- Mitsubishi Electric Corporation
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | November 2024 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 1.04 Billion |
| Forecasted Market Value ( USD | $ 2.67 Billion |
| Compound Annual Growth Rate | 10.9% |
| Regions Covered | United States |
| No. of Companies Mentioned | 5 |
